共查询到20条相似文献,搜索用时 15 毫秒
1.
ANDREA CORRADO M.D. ALDO BONSO M.D. MICHELA MADALOSSO M.D. ANTONIO ROSSILLO M.D. SAKIS THEMISTOCLAKIS M.D. LUIGI DI BIASE M.D. † ‡ REA NATALE M.D. † ANTONIO RAVIELE M.D. 《Journal of cardiovascular electrophysiology》2010,21(1):1-5
Impact of the Systematic Isolation of the Superior Vena Cava. Background: Pulmonary veins (PVs) have been shown to represent the most frequent sites of ectopic beats initiating paroxysmal atrial fibrillation (AF). However, additional non-PV triggers, arising from different areas, have been reported as well. One of the most common non-PV sites described is the superior vena cava.
Aims: The purpose of the study was to investigate the impact resulting from the systematic isolation of the superior vena cava (SVCI) in addition to pulmonary vein antrum isolation (PVAI) on the outcome of paroxysmal, persistent, and permanent AF ablation.
Methods: A total of 320 consecutive patients who had been referred to our center in order to undergo a first attempt of AF ablation were randomized into 2 groups. Group I (160 patients) underwent PVAI only; Group II (160 patients) underwent PVAI and SVCI.
Results: AF was paroxysmal in 134 (46%), persistent in 75 (23%), and permanent in 111 (31%) of said patients. SVCI was performed on 134 of the 160 patients (84%) in Group II. SVC isolation was not performed on the remaining 26 patients either because of phrenic nerve capture or the lack of SVC potentials. Comparison of the outcome data between the 2 groups, after a follow-up of 12 months, revealed a significant difference in total procedural success solely with patients manifesting paroxysmal atrial fibrillation (56/73 [77%] Group I vs. 55/61 [90%] Group II; P = 0.04; OR 2.78).
Conclusions: In our study, the strategy of the empiric SVCI in addition to PVAI has improved the outcome of AF ablation solely in patients manifesting paroxysmal AF. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1–5, January 2010) 相似文献
Aims: The purpose of the study was to investigate the impact resulting from the systematic isolation of the superior vena cava (SVCI) in addition to pulmonary vein antrum isolation (PVAI) on the outcome of paroxysmal, persistent, and permanent AF ablation.
Methods: A total of 320 consecutive patients who had been referred to our center in order to undergo a first attempt of AF ablation were randomized into 2 groups. Group I (160 patients) underwent PVAI only; Group II (160 patients) underwent PVAI and SVCI.
Results: AF was paroxysmal in 134 (46%), persistent in 75 (23%), and permanent in 111 (31%) of said patients. SVCI was performed on 134 of the 160 patients (84%) in Group II. SVC isolation was not performed on the remaining 26 patients either because of phrenic nerve capture or the lack of SVC potentials. Comparison of the outcome data between the 2 groups, after a follow-up of 12 months, revealed a significant difference in total procedural success solely with patients manifesting paroxysmal atrial fibrillation (56/73 [77%] Group I vs. 55/61 [90%] Group II; P = 0.04; OR 2.78).
Conclusions: In our study, the strategy of the empiric SVCI in addition to PVAI has improved the outcome of AF ablation solely in patients manifesting paroxysmal AF. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1–5, January 2010) 相似文献
2.
3.
4.
ANDREAS METZNER M.D. PETER RAUSCH M.D. CHRISTINE LEMES M.D. BRUNO REISSMANN M.D. ALEXANDER BARDYSZEWSKI M.D. ROLAND TILZ M.D. ANDREAS RILLIG M.D. SHIBU MATHEW M.D. SEBASTIAN DEISS M.D. MASASHI KAMIOKA M.D. TOBIAS TOENNIS M.D. TINA LIN M.D. FEIFAN OUYANG M.D. KARL‐HEINZ KUCK M.D. ERIK WISSNER M.D. 《Journal of cardiovascular electrophysiology》2014,25(5):466-470
5.
Pulmonary Vein Isolation Using a Second‐Generation Cryoballoon in Patients With Paroxysmal Atrial Fibrillation: One‐Year Outcome Using a Single Big‐Balloon 3‐Minute Freeze Technique
下载免费PDF全文
![点击此处可从《Journal of cardiovascular electrophysiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
SHINSUKE MIYAZAKI M.D. HITOSHI HACHIYA M.D. HIROAKI NAKAMURA M.D. HIROSHI TANIGUCHI M.D. TAKAMITSU TAKAGI M.D. KENZO HIRAO M.D. YOSHITO IESAKA M.D. 《Journal of cardiovascular electrophysiology》2016,27(12):1375-1380
6.
7.
GIUSEPPE CICONTE M.D. GIAN‐BATTISTA CHIERCHIA M.D. Ph.D. CARLO DE ASMUNDIS M.D. Ph.D. JUAN SIEIRA M.D. GIULIO CONTE M.D. JUSTO JULIÁ M.D. GIACOMO DI GIOVANNI M.D. KRISTEL WAUTERS M.D. GIANNIS BALTOGIANNIS M.D. Ph.D. YUKIO SAITOH M.D. GIACOMO MUGNAI M.D. DOMENICO CATANZARITI M.D. CLAUDIO TONDO M.D. Ph.D. PEDRO BRUGADA M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2014,25(8):845-851
8.
9.
10.
11.
12.
EVGENY POKUSHALOV M.D. Ph.D. ALEXANDER ROMANOV M.D. SERGEY ARTYOMENKO M.D. VERA BARANOVA M.D. DENIS LOSIK M.D. SEVDA BAIRAMOVA M.D. ALEXANDER KARASKOV M.D PhD. SUNEET MITTAL M.D. JONATHAN S. STEINBERG M.D. 《Journal of cardiovascular electrophysiology》2013,24(3):274-279
Cryoballoon versus Radiofrequency Ablation . Aim: Catheter ablation of paroxysmal atrial fibrillation (PAF) is associated with an important risk of early and late recurrence, necessitating repeat ablation procedures. The aim of this prospective randomized patient‐blind study was to compare the efficacy and safety of cryoballoon (Cryo) versus radiofrequency (RF) ablation of PAF after failed initial RF ablation procedure. Methods: Patients with a history of symptomatic PAF after a previous failed first RF ablation procedure were eligible for this study. Patients were randomized to Cryo or RF redo ablation. The primary endpoint of the study was recurrence of atrial tachyarrhythmia, including AF and left atrial flutter/tachycardia, after a second ablation procedure at 1 year of follow‐up. All patients were implanted with a cardiac monitor (Reveal XT, Medtronic) to continuously track the cardiac rhythm. Patients with an AF burden (AF%) ≤ 0.5% were considered AF‐free (Responders), while those with an AF% > 0.5% were classified as patients with AF recurrences (non‐Responders). Results: Eighty patients with AF recurrences after a first RF pulmonary vein isolation (PVI) were randomized to Cryo (N = 40) or to RF (N = 40). Electrical potentials were recorded in 77 mapped PVs (1.9 ± 0.8 per patient) in Cryo Group and 72 PVs (1.7 ± 0.8 per patient) in RF Group (P = 0.62), all of which were targeted. In Cryo group, 68 (88%) of the 77 PVs were re‐isolated using only Cryo technique; the remaining 9 PVs were re‐isolated using RF. In RF group, all 72 PVs were successfully re‐isolated (P = 0.003 vs Cryo). By intention‐to‐treat, 23 (58%) RF patients were AF‐free vs 17 (43%) Cryo patients on no antiarrhythmic drugs at 1 year (P = 0.06). Three patients had temporary phrenic nerve paralysis in the Cryo group; the RF group had no complications. Of the 29 patients who had only Cryo PVI without any RF ablation, 11 (38%) were AF‐free vs 20 (59%) of the 34 patients who had RF only (P = 0.021). Conclusion: When patients require a redo pulmonary vein isolation ablation procedure for recurrent PAF, RF appears to be the preferred energy source relative to Cryo. (J Cardiovasc Electrophysiol, Vol. 24, pp. 274‐279, March 2013) 相似文献
13.
K. R. JULIAN CHUN M.D. † ALEXANDER FÜRNKRANZ M.D. † REAS METZNER M.D. † BORIS SCHMIDT M.D. † ROLAND TILZ M.D. † THOMAS ZERM M.D. † ILKA KÖSTER M.D. † DIETER NUYENS M.D. † ERIK WISSNER M.D. † FEIFAN OUYANG M.D. † KARL HEINZ KUCK M.D. † 《Journal of cardiovascular electrophysiology》2009,20(11):1203-1210
Introduction: Cryoballoon (CB) ablation represents a novel technology for pulmonary vein isolation (PVI). We investigated feasibility and safety of CB-PVI, utilizing a novel spiral catheter (SC), thereby obtaining real-time PV potential registration.
Methods: Following double transseptal puncture, a Lasso catheter (Biosense Webster, Diamond Bar, CA, USA) and the 28 mm CB were positioned within the left atrium. A novel SC (Promap, ProRhythm Inc., Ronkonkoma, NY, USA) was inserted through the lumen of the CB allowing PV signal registration during treatment. Time to PV conduction block was analyzed. If no stable balloon position was obtained, the SC was exchanged for a regular guide wire and PV conduction was assessed after treatment by Lasso catheter.
Results: In 18 patients, 39 of 72 PVs (54%) were successfully isolated using the SC. The remaining 33 PVs were isolated switching to the regular guide wire. Time to PV conduction block was significantly shorter in PVs in which sustained PVI was achieved as compared to PVs in which PV conduction recovered within 30 minutes (33 ± 21 seconds vs 99 ± 65 seconds). In 40 PVs, time to PV conduction block was not obtained because of: (1) PVI not being achieved during initial treatment; (2) a distal position of the SC; or (3) isolation with regular guide wire. No procedural complications occurred.
Conclusion: Visualization of real-time PV conduction during CB PVI is safe, feasible, and allows accurate timing of PVI onset in a subset of PVs. Time to PV conduction block predicts sustained PVI. However, mechanical properties of the SC need to be improved to further simplify CB PVI. 相似文献
Methods: Following double transseptal puncture, a Lasso catheter (Biosense Webster, Diamond Bar, CA, USA) and the 28 mm CB were positioned within the left atrium. A novel SC (Promap, ProRhythm Inc., Ronkonkoma, NY, USA) was inserted through the lumen of the CB allowing PV signal registration during treatment. Time to PV conduction block was analyzed. If no stable balloon position was obtained, the SC was exchanged for a regular guide wire and PV conduction was assessed after treatment by Lasso catheter.
Results: In 18 patients, 39 of 72 PVs (54%) were successfully isolated using the SC. The remaining 33 PVs were isolated switching to the regular guide wire. Time to PV conduction block was significantly shorter in PVs in which sustained PVI was achieved as compared to PVs in which PV conduction recovered within 30 minutes (33 ± 21 seconds vs 99 ± 65 seconds). In 40 PVs, time to PV conduction block was not obtained because of: (1) PVI not being achieved during initial treatment; (2) a distal position of the SC; or (3) isolation with regular guide wire. No procedural complications occurred.
Conclusion: Visualization of real-time PV conduction during CB PVI is safe, feasible, and allows accurate timing of PVI onset in a subset of PVs. Time to PV conduction block predicts sustained PVI. However, mechanical properties of the SC need to be improved to further simplify CB PVI. 相似文献
14.
Point‐by‐Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial)
下载免费PDF全文
![点击此处可从《Journal of cardiovascular electrophysiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
ROSS J. HUNTER Ph.D. F.E.S.C. VICTORIA BAKER M.Sc. MALCOLM C. FINLAY M.R.C.P. Ph.D. EDWARD R. DUNCAN M.R.C.P. Ph.D. MATTHEW J. LOVELL M.R.C.P. Ph.D. MUZAHIR H. TAYEBJEE M.D. M.R.C.P. WAQAS ULLAH M.R.C.P. M. SHOAIB SIDDIQUI M.R.C.P. AILSA McLEAN M.Sc. LAURA RICHMOND M.Sc. CLAIRE KIRKBY M.Sc. MATTHEW R. GINKS M.D. M.R.C.P. MEHUL DHINOJA M.R.C.P. SIMON SPORTON M.D. F.R.C.P. MARK J. EARLEY M.D. F.R.C.P. RICHARD J. SCHILLING M.D. F.R.C.P. 《Journal of cardiovascular electrophysiology》2015,26(12):1307-1314
15.
GEORG NÖLKER M.D. JOHANNES HEINTZE M.D. KLAUS‐JÜRGEN GUTLEBEN M.D. BOGDAN MUNTEAN M.D. VANESSA PÜTZ M.D. AMEERA YALDA M.D. JÜRGEN VOGT M.D. DIETER HORSTKOTTE M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2010,21(12):1325-1330
Intracardiac Echo Supported Cryoballoon Ablation . Introduction: Cryoballoon ablation has been adopted for pulmonary vein (PV) isolation (PVI) in many centers. Complete occlusion of PV by an adequately sized balloon is crucial for effectiveness of cryoenergy delivery. The aim of this study was to evaluate intracardiac echocardiography (ICE) as an alternative imaging technique compared to angiographic imaging in cryoballoon PVI. Methods and Results: A total of 75 PVs were treated in 22 patients (61 ± 13 years, 17 male) undergoing PV cryoballoon ablation for drug refractory paroxysmal atrial fibrillation. Decision for an adequate balloon size was based on diameters of the PV antra assessed by ICE and PV angiography. Per PV 2.4 ± 0.4 cryoenergy pulses were applied. Decision for the balloon size was similar either based upon angiography or on ICE. A single 23 or 28 mm balloon was chosen in 10 and 3 patients, respectively. Two different sized balloons were used in 9 patients. PVI was evaluated after 2 cryoenergy applications. Total occlusion of the PV confirmed by ICE color flow Doppler (CFD) during ablation predicted successful PVI in 70 of 75 (93%) and unsuccessful PVI in 8 of 8 (100%). PV flow registered by pulsed wave Doppler at the PV ostium pre‐ and postablation was 0.48 ± 0.10 and 0.51 ± 0.12 m/s, respectively (n.s.). PVI was finally confirmed by entrance block in all PVs. No procedural complications occurred. Conclusions: ICE is a feasible novel imaging technique in cryoballoon ablation procedures. It allows decision for adequate balloon size, exact balloon placement, prediction of acute ablation success, and excludes acute narrowing of PV ostia. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1325‐1330, December 2010) 相似文献
16.
SHINSUKE MIYAZAKI M.D. NICOLAS DERVAL M.D. ASHOK SHAH M.D. OLIVIER XHAET M.D. MICHEL HAÏSSAGUERRE M.D. 《Journal of cardiovascular electrophysiology》2011,22(3):343-345
Mitral Isthmus Block in Superior Vena Cava . Persistent left superior vena cava (LSVC), an uncommon venous anomaly, could be an arrhythmogenic source of atrial fibrillation. Multiple electrical connections were reported between the LSVC and the left atrium, which may negatively impact the achievement of conduction block during linear ablation of left mitral isthmus. We describe a case with perimitral atrial flutter (AFL) in a patient with isolated LSVC. AFL was successfully treated and complete perimitral conduction block was achieved following a lengthy epicardial radiofrequency application. (J Cardiovasc Electrophysiol, Vol. 22, pp. 343‐345, March 2011) 相似文献
17.
Phrenic Nerve Injury During Isolation of the Superior Vena Cava: Prevention Using Diaphragmatic Compound Motor Action Potentials – “Primum Nil Nocere.”
下载免费PDF全文
![点击此处可从《Journal of cardiovascular electrophysiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
THOMAS DENEKE M.D. F.H.R.S. ANDREAS MÜGGE M.D. F.A.C.C. KARIN NENTWICH M.D. PHILIPP HALBFAß M.D. 《Journal of cardiovascular electrophysiology》2016,27(4):396-398
18.
19.
Prospective Evaluation of Electromyography‐Guided Phrenic Nerve Monitoring During Superior Vena Cava Isolation to Anticipate Phrenic Nerve Injury
下载免费PDF全文
![点击此处可从《Journal of cardiovascular electrophysiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
SHINSUKE MIYAZAKI M.D. NOBORU ICHIHARA M.D. HIROAKI NAKAMURA M.D. HIROSHI TANIGUCHI M.D. HITOSHI HACHIYA M.D. MAKOTO ARAKI M.D. TAKAMITSU TAKAGI M.D. JIN IWASAWA M.D. AKIO KUROI M.D. KENZO HIRAO M.D. YOSHITO IESAKA M.D. 《Journal of cardiovascular electrophysiology》2016,27(4):390-395
20.
Second‐Generation Cryoballoon Ablation in the Setting of Lone Paroxysmal Atrial Fibrillation: Single Procedural Outcome at 12 Months
下载免费PDF全文
![点击此处可从《Journal of cardiovascular electrophysiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
DARRAGH MORAN M.D. BURAK HÜNÜK M.D. ERWIN STRÖKER M.D. EBRU HACIOGLU M.D. DIEGO RUGGIERO M.D. HUGO ENRIQUE COUTIÑO‐MORENO M.D. KEN TAKARADA M.D. PEDRO BRUGADA M.D. Ph.D. CARLO DE ASMUNDIS M.D. Ph.D. GIAN‐BATTISTA CHIERCHIA M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2016,27(6):677-682